These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18617442)

  • 61. Blood centers and hospitals: a model for clinical interaction and services.
    Gottschall JL
    Transfusion; 2007 Aug; 47(2 Suppl):172S-175S; discussion 182S-183S. PubMed ID: 17651346
    [No Abstract]   [Full Text] [Related]  

  • 62. The emerging chemistry of blood product disinfection.
    Wainwright M
    Chem Soc Rev; 2002 Mar; 31(2):128-36. PubMed ID: 12109206
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Are inactivation procedures for blood products good or bad?
    Caspari G
    BMJ; 2002 Nov; 325(7372):1116. PubMed ID: 12424183
    [No Abstract]   [Full Text] [Related]  

  • 64. [Understanding the role of the European public institutions in blood transfusion].
    Behr-Gross ME
    Transfus Clin Biol; 2009 May; 16(2):237-40. PubMed ID: 19443256
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
    Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
    Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Could cells from menstrual blood be a new source for cell-based therapies?
    Zhang MJ; Liu B; Xia W; Sun ZY; Lu KH
    Med Hypotheses; 2009 Mar; 72(3):252-4. PubMed ID: 19101090
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Laboratory safe detection of nucleocapsid protein of Rift Valley fever virus in human and animal specimens by a sandwich ELISA.
    Jansen van Vuren P; Paweska JT
    J Virol Methods; 2009 Apr; 157(1):15-24. PubMed ID: 19124041
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Current methods of isolating blood components in relation to the experience of the blood transfusion center of the Central Scientific-Research Institute of Hematology and Blood Transfusion].
    Makarova EM; Demicheva MI; Egorov VM; Gurtovoĭ IM; Belorusova VA
    Gematol Transfuziol; 1986 Oct; 31(10):57-60. PubMed ID: 3792814
    [No Abstract]   [Full Text] [Related]  

  • 69. Clinical trials in apheresis.
    Stefanutti C
    Ther Apher Dial; 2009 Jun; 13(3):171-3. PubMed ID: 19527461
    [No Abstract]   [Full Text] [Related]  

  • 70. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.
    Goodrich RP; Gilmour D; Hovenga N; Keil SD
    Transfusion; 2009 Jun; 49(6):1205-16. PubMed ID: 19320867
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Solar radiation disinfection of drinking water at temperate latitudes: inactivation rates for an optimised reactor configuration.
    Davies CM; Roser DJ; Feitz AJ; Ashbolt NJ
    Water Res; 2009 Feb; 43(3):643-52. PubMed ID: 19041999
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Blood components: current challenges.
    Rouger P
    Transfus Clin Biol; 2007 Dec; 14(6):496-8. PubMed ID: 18420438
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Improvements in early mortality and coagulopathy are sustained better in patients with blunt trauma after institution of a massive transfusion protocol in a civilian level I trauma center.
    Dente CJ; Shaz BH; Nicholas JM; Harris RS; Wyrzykowski AD; Patel S; Shah A; Vercruysse GA; Feliciano DV; Rozycki GS; Salomone JP; Ingram WL
    J Trauma; 2009 Jun; 66(6):1616-24. PubMed ID: 19509623
    [TBL] [Abstract][Full Text] [Related]  

  • 75. UV inactivation and resistance of rotavirus evaluated by integrated cell culture and real-time RT-PCR assay.
    Li D; Gu AZ; He M; Shi HC; Yang W
    Water Res; 2009 Jul; 43(13):3261-9. PubMed ID: 19501383
    [TBL] [Abstract][Full Text] [Related]  

  • 76. It is time to bring back solvent-detergent plasma.
    Sandler SG
    Curr Opin Hematol; 2007 Nov; 14(6):640-1. PubMed ID: 17898568
    [No Abstract]   [Full Text] [Related]  

  • 77. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Blajchman MA
    Transfus Clin Biol; 2009 May; 16(2):70-4. PubMed ID: 19427252
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Pumping coagulated blood from the coronary vessels during during initial care of a patient with sharp pain in heart muscles].
    Finkelstein A; Keren G; Banai S
    Harefuah; 2008 Oct; 147(10):818-9. PubMed ID: 19039915
    [No Abstract]   [Full Text] [Related]  

  • 79. Platelets, frozen plasma, and cryoprecipitate: what is the clinical evidence for their use in the neonatal intensive care unit?
    Poterjoy BS; Josephson CD
    Semin Perinatol; 2009 Feb; 33(1):66-74. PubMed ID: 19167583
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
    Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
    J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.